LONDON, March 21, 2018 -- According to this latest publication from Meticulous Research™, NGS services market to reach USD 2,921.4 million by 2023, growing at a CAGR of 20.1% during the forecast period of 2018 to 2023. “Plummeting cost of sequencing, growing need of skilled professionals for efficient NGS sample preparation and analysis, technological advancements, increase in genome mapping programs, and high cost of sequencing infrastructure are the major factors driving the growth of NGS services market”, mentions Meticulous Research™.
The report also notes that, “growing application of NGS technology in cancer and agrigenomics research for the analysis of complex sequencing data and rising demand for personalized medicine provides significant opportunities to NGS service providers.”
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=3875
Geographically, North America dominated the global NGS services market in 2017, mainly due to the increasing burden of chronic and infectious diseases, growing R&D expenditure, various government initiatives, and the presence of many services providers in this region.
The key players in the global NGS services market are Illumina, Inc., Qiagen N.V., PerkinElmer, Inc., Eurofins Scientific SE, GATC Biotech AG, Macrogen, Inc., Genotypic Technology Pvt. Ltd., GENEWIZ, Inc., Beijing Genomics Institute, SciGenom Labs Pvt. Ltd., MedGenome, DNA Link, Inc., Otogenetics Corporation, Novogene Corporation, LGC Limited, CD Genomics, and SeqLL, LLC.
Full News: https://www.meticulousresearch.com/next-generation-sequencing-ngs-services-market-2023/
Scope of the Report:
Market by Service Type:
- Targeted Sequencing
- RNA Sequencing
- Exome Sequencing
- De Novo Sequencing
- ChIP-Sequencing
- Whole Genome Sequencing
- Methyl Sequencing
- Other Services
Market by Technology:
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing (IOS)
- Single Molecule Real Time Sequencing (SMRT)
- Nanopore Sequencing
- True Single Molecule Sequencing (tSMS)
Market by Application:
- Diagnostics
- Drug Discovery
- Biomarker Discovery
- Agriculture & Animal Research
- Other Applications
Market by End User:
- Academic & Research Institutes
- Pharmaceuticals & Biotechnology Industry
- Hospitals & Clinics
- Other End Users
Market by Geography:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Browse in-depth report here: https://www.meticulousresearch.com/product/next-generation-sequencing-ngs-services-market/
Contact Info:
Viren Shrivastava
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)


Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Apple Restores Telegram to App Store After Content Policy Violation
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 



